pharmaphorum

APRIL 5, 2022

It’s no secret that digital technologies are playing a significant role when it comes to shaping the next era of healthcare. Necessity accelerated the adoption of new and sophisticated technologies and systems throughout the COVID-19 pandemic, but this seismic shift towards digital health has opened up a gap in education. To successfully navigate the potential of digital technologies in healthcare, attention must be focused on upskilling professionals in the field to equip them with the necessar

124

124

Outsourcing Pharma

APRIL 7, 2022

The US Department of Health and Human Serviceâs Office of Research Integrity has uncovered evidence that Toni Brand committed fraud in a number of reports.

83

83

Board Vitals - Pharmacist

APRIL 8, 2022

Funding is something that must be considered when determining your undergraduate and graduate academic goals for nursing school. Nursing school is expensive. Depending on the type of school and nursing program you enroll in, total tuition can range from $6,000 for an associate degree to $100,000 for an advanced degree. Luckily, many organizations offer funding options to nursing students from grants to student loans to scholarships.

Medical Schools 52

Medical Schools 52

Pharma Mirror

APRIL 8, 2022

Cambridge, UK, CellCentric, aclinical stage, private biotechnology company pioneering small molecule inhibition of p300/CBP to treat cancer, today announces the appointments of Kris Frese as Director of Cancer Biology, and Andrew Hughes, who joins the Board as a Non-Executive Director. Both have stellar experience and track records in oncology research and development.

52

52

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

pharmaphorum

APRIL 6, 2022

Ensuring that patients remain consistent with their therapies is one of the major challenges facing healthcare, so what if you could make treatment a game? That’s the potential behind game-based digital therapeutics and it’s drawing a lot of interest, finds Ben Hargreaves. The impact of video games on modern culture can be felt by even those that have little or no interest in them.

FDA 111

FDA 111

Outsourcing Pharma

APRIL 6, 2022

The excipients, equipment, and API companies have joined forces on Inhalation Together, an initiative aimed at advancing dry-powder inhalation solutions.

78

78

Pharma Mirror

APRIL 8, 2022

BARCELONA, Spain and Dundee, UK, a global biopharmaceutical company focused on skin health, today announced a research collaboration with the University of Dundee, a top-ranked university in the UK in biological sciences, to develop a novel approach against chronic and debilitating dermatology diseases where itch, or pruritus, plays a dominant role.

Immunization 52

Immunization 52

pharmaphorum

APRIL 4, 2022

The National Institutes of Health (NIH) is funding a nationwide study in the US to support research on long-COVID, chronic COVID, or as it’s scientifically known, post-acute sequelae of SARS-CoV-2 (PASC) in children. An estimated 10% to 30% of adults who contract COVID-19 suffer from long COVID. Though speciality departments and independent institutions have opened to study chronic COVID in adults, little research has been done to evaluate the long-term effects of the virus on children.

Vaccines 111

Vaccines Hospitals Dosage Immunization 111

Outsourcing Pharma

APRIL 5, 2022

Leaders from some of the industryâs most notable companies are working together to streamline and automate IDMP workflow and come up with various standards.

76

76

PharmD Live

APRIL 6, 2022

By PharmD Live Staff Writer. The Social Determinants of Health in the African-American community include all of the factors of the U.S. Government’s Healthy People 2030, a set of data-driven national goals for improving health for all Americans. Included is a focus on the Merit-based Incentive Pay System (MIPS). From poverty to food insecurity and violence, the history of racism can’t be ignored as a social determinant of health today.

Communication 52

Communication Hospitals 52

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharma Mirror

APRIL 7, 2022

Let’s face it, dealing with a terminal illness diagnosis will never be an easy task and there’s not much you can do to mitigate the pain. However, there are a few steps that you can take to make the whole ordeal a bit more manageable for the person diagnosed and those around them. There are a few emotional chapters you’ll need to close as well as some practical matters that you should get out of the way if you are diagnosed with a terminal illness.

52

52

pharmaphorum

APRIL 8, 2022

Jazz Pharma has bolstered its pipeline of cancer drugs through a $1.3 billion licensing agreement with Werewolf Therapeutics that adds its first immuno-oncology candidate. The Dublin-based pharma is paying $15 million upfront for global rights to Werewolf’s WTX-613, a prodrug of the cytokine interferon alfa-2b, which is still back n preclinical development and due to start its first clinical trials next year.

Immunization 105

Immunization 105

Outsourcing Pharma

APRIL 7, 2022

Experts from the Decentralized Trials and Research Alliance and Rafael Pharmaceuticals discuss progress and possibilities during Clinical Development Advances.

75

75

Pharma Marketing Network

APRIL 4, 2022

The American Academy of Dermatology (AAD) held its annual conference last weekend, and it was my privilege to be in attendance. As COVID-19 had put the brakes on the show for the past two years, that same sentiment was shared by most of the attendees and exhibitors this year. Admittedly, attendance was down slightly from previous years, but that just meant shorter lines and extra opportunity to learn at each booth, and I have no doubt that it will exceed its former glory once COVID goes the way

52

52

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharma Mirror

APRIL 6, 2022

London, ATMPS Ltd/Hataali – the leader in blockchain-based data sharing platforms for advanced therapies – announces it has been granted a patent from the United States Patent and Trademark Office (USPTO) for the use of blockchain technologies in personalised medicines. The company also has applications pending in both Europe and Asia as it looks to cement its technological advantage in the rapidly growing advanced therapy space globally.

52

52

pharmaphorum

APRIL 6, 2022

2021 was a big year in investment financing for US digital health companies, but there are signs that it may be a high watermark. In the first three months of this year there were 183 deals worth a total of $6 billion, giving an average size per deal of just under $33 million, according to venture fund Rock Health’s latest update on the sector.

104

104

Outsourcing Pharma

APRIL 5, 2022

Novartis has created a new organizational structure and operating model: which it says will make the company more agile and competitive.

52

52

Pharma Times

APRIL 8, 2022

Alexion Pharma UK, AstraZeneca’s Rare Disease group, announces the recommendation of its pivotal neurofibromatosis treatment

48

48

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharma Mirror

APRIL 6, 2022

GENT, BELGIUM, eTheRNA immunotherapies NV (“eTheRNA”), an mRNA technology discovery and development company with a full platform of integrated capabilities, is pleased to announce the relocation of its R&D group to a new and larger site in Gent, Belgium. The upgraded R&D facility is in the Zwijnaarde Science Park, where a cluster of biotech companies are located, and includes state-of-the-art laboratories together with allied services.

52

52

pharmaphorum

APRIL 7, 2022

For some years industry observers have been asking what Merck & Co can do to reduce its reliance on blockbuster cancer immunotherapy Keytruda. Now, it seems a key part of that effort will come from its cardiovascular disease pipeline. During an R&D update yesterday Merck said it is hoping to claim eight new cardiovascular therapy approvals between now and 2030, for diseases like atherosclerosis, heart failure, pulmonary arterial hypertension (PAH) and thrombosis, as it hunts down $10 bil

Research Laboratories 98

Research Laboratories 98

Outsourcing Pharma

APRIL 4, 2022

Working with numerous partners, DiMe has introduced the 3Ps of Digital Endpoint Value to help inclusion of digital endpoints in drug reimbursement decisions.

52

52

Pharma Times

APRIL 6, 2022

A technique developed by the University of Birmingham demonstrates link between patients’ alpha brain waves and responses to pain

47

47

Pharma Mirror

APRIL 6, 2022

New York, Kicking off the season for pharmaceutical professionals to come together digitally (09-27 May, 2022) as well as in-person (17-19 May, 2022). CPHI North America will be held as a SMART event, with three weeks of dedicated pharma learning and partnering. The benefit for the CPHI pharma community, which relies on a widening global supply chain, is that a SMART event format stimulates greater collaboration within the industry.

52

52

pharmaphorum

APRIL 6, 2022

Boehringer Ingelheim says it is planning to invest a hefty €25 billion ($27 billion) in its pipeline over the next five years, as it reinvests healthy sales revenue from Eli Lilly-partnered SGLT2 inhibitor Jardiance. The German group has just reported a 28% increase in Jardiance (empagliflozin) sales to €3.9 billion in 2021, buoyed by new approval in heart failure, which was accompanied by a 25% gain for pulmonary fibrosis therapy Ofev (nintedanib) to €2.5 billion.

FDA 98

FDA 98

Med Ed 101

APRIL 6, 2022

In this COPD case study, we outline how to use the GOLD guidelines to guide medication therapy. Here’s the case! KE is a 71-year-old male who has a history of cigarette smoking for 50+ years, COPD, cardiovascular disease, hypertension, peripheral arterial disease, GERD, and osteoarthritis. His primary concern is his breathing and COPD. He presents […].

45

45

Pharma Times

APRIL 4, 2022

Investments will enhance the development of lipid systems manufacturing, while also boosting the development of gene therapies

47

47

SingleCare

APRIL 7, 2022

When a patient brings their prescription to the pharmacy, the prescription doesn’t automatically get filled without question. As a pharmacist, you need to review the details to make sure it is valid and safe to dispense. This process can be hindered if you find the patient is at risk of misusing the drug or experiencing harmful side effects. In several states, pharmacists can even refuse to fill the prescription if they believe dispensing the drug goes against the optimal care of the patient or

Health and Personal Care Stores 52

Health and Personal Care Stores HIPAA Prescription Filling Dosage 52

pharmaphorum

APRIL 5, 2022

Oliver Stohlmann’s Corporate Survival Hacks series draws on his experiences of working in local, regional and global life science communications to offer some little tips for enjoying a big business career. This post helps you prepare and conduct difficult yet respectful conversations with colleagues individually or in group settings. No, you don’t do that.

Communication 98

Communication 98

Med Ed 101

APRIL 3, 2022

Asthma and COPD are two disease states that we need to use inhalers. As a clinical pharmacist, I understand the importance of patient education. I’ve seen numerous mistakes with inhaler technique over the years in my practice as a clinical pharmacist. Here are some of those examples. Shaking The Inhaler I’ve seen this mistake go […].

45

45

Pharma Times

APRIL 7, 2022

NICE recommends avelumab as treatment for adults with locally advanced or metastatic urothelial cancer

46

46

pharmaphorum

APRIL 8, 2022

With more than 6,000 different diseases comprising the rare disease (RD) landscape, connecting patients and practitioners with the expertise needed to achieve the correct diagnosis can be a significant barrier to treatment. . As the severity, progress and treatment potential of RD varies from patient to patient, each condition needs to be addressed differently using specialist expertise.

Hospitals 78

Hospitals 78

pharmaphorum

APRIL 4, 2022

Gilead Sciences’ Kite Pharma has become the first drugmaker to get FDA approval to use a CAR-T therapy after just one earlier systemic therapy, moving the approach up the treatment pathway. The US regulator has cleared Kite’s CD19-targeted CAR-T Yescarta (axicabtagene ciloleucel) for people with large B-cell lymphoma (LBCL) refractory to one earlier therapy, or who have relapsed within 12 moths of first-line chemo-immunotherapy.

FDA 69

FDA Insurance 69

pharmaphorum

APRIL 5, 2022

Researchers at the Institute of Cancer Research (ICR) in London have designed a prototype test that they think could be used to predict which combinations are likely to work in cancer patients within two days. The technique uses artificial intelligence (AI) to analyse protein data harvested from tumour cells, using an algorithm trained by looking at changes to 52 proteins when they are exposed to a panel of targeted anticancer drugs.

67

67